This Aug. 24, 2010 photo provided by Genomic Health shows the packaging for their Oncotype DX kit for assessing prostate cancer risk. This kit and another made available in 2012 are intended to gauge ... more 
This Aug. 24, 2010 photo provided by Genomic Health shows the packaging for their Oncotype DX kit for assessing prostate cancer risk. This kit and another made available in 2012 are intended to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The Oncotype test is planed to be discussed Wednesday, May 8, 2013 at an American Urological Association conference. (AP Photo/Myriad Genetics) less 
1 / 24
Associated Press | Photo By Myriad Genetics
Wed, May 8, 2013 9:56 AM EDT